UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063602
Receipt number R000072685
Scientific Title Usability Study of a Digital Therapeutic App for Patients with Major Depressive Disorder
Date of disclosure of the study information 2026/11/12
Last modified on 2026/11/12 00:14:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study to Evaluate the Usability of a Digital App for Treating Depression

Acronym

Depression App Usability Study

Scientific Title

Usability Study of a Digital Therapeutic App for Patients with Major Depressive Disorder

Scientific Title:Acronym

Digital Therapeutic App Usability Study

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm that the Japanese-language user interface of a digital therapeutic app for patients with major depressive disorder can be used safely and appropriately by Japanese users and that use-related problems attributable to the user interface have been adequately reduced.

Basic objectives2

Others

Basic objectives -Others

Usability evaluation of the Japanese-translated and localized user interface

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Task performance during simulated use. Based on observation by study personnel, each task will be classified as Success, Difficulty, Use Error, or Not Attempted. Assessment will be conducted during each task.

Key secondary outcomes

1. Root causes of problems and participants' subjective feedback for tasks classified as Difficulty or Use Error, assessed through questions after the relevant task or after use.
2. Classification of the causes of observed use errors into Perception, Cognition, or Action.
3. Participants' perception and understanding of safety-related information and their ability to take appropriate action in anticipated scenarios, assessed within a single study session.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Japanese adults aged 18 years or older at the time of informed consent.
2.Able to communicate, read, and write in Japanese.
3.Regular users of an iOS or Android smartphone who are able to perform basic smartphone operations.
4.Able to provide written informed consent to participate in this study.

Key exclusion criteria

1.Individuals who have difficulty fully understanding the purpose or procedures of the study.
2.Individuals who have difficulty operating a smartphone or participating in the study throughout its duration.
3.Individuals with professional knowledge of or prior experience using this app or similar digital therapeutic apps for depression that may affect the usability evaluation.
4.Individuals otherwise considered unsuitable for participation by the study personnel.

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Koji
Middle name
Last name Ohnishi

Organization

Otsuka Pharmaceutical Co., Ltd.

Division name

Digital Business Office

Zip code

108-8242

Address

Shinagawa Grand Central Tower 2-16-4 Konan, Minato-ku, Tokyo, Japan

TEL

03-6717-1400

Email

ohnishiko@otsuka.jp


Public contact

Name of contact person

1st name Naoto
Middle name
Last name Aizawa

Organization

Uism KK

Division name

Research Department

Zip code

151-0053

Address

BizSmart 5F, 1-25-5 Yoyogi, Shibuya-ku, Tokyo, Japan

TEL

03-6869-3048

Homepage URL


Email

naoto.aizawa@uism.co.jp


Sponsor or person

Institute

Otsuka Pharmaceutical Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation TOUKEIKAI Kitamachi Clinic ERB

Address

1-1-3, Kichijoji-kitamachi, Musashino-shi, Tokyo, Japan

Tel

03-6779-8116

Email

chi-pr-ec-kitamachi@cmicgroup.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

STEP B-1ルーム


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

6

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2026 Year 08 Month 28 Day

Date of IRB

2026 Year 09 Month 16 Day

Anticipated trial start date

2026 Year 11 Month 12 Day

Last follow-up date

2026 Year 11 Month 13 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study evaluates the usability of the Japanese-language digital therapeutic app for patients with major depressive disorder through simulated use by healthy adults.


Management information

Registered date

2026 Year 11 Month 12 Day

Last modified on

2026 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072685